Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Australian-based biotech company identifies new breast cancer target protein
August 15th, 2005
Meditech Research Ltd (MTR), am Australian-based biotechnology company developing new cancer therapies, announced that preclinical research describing the identification of a new breast cancer target protein has been published in the latest edition of Cancer Research, a publication of the American Association for Cancer Research, Inc. (AACR). A target is a specific protein found within a cancer tumor. The potential new therapeutic target is a protein (HAS2) involved in the biosynthesis of hyaluronic acid, which was identified by workers in the Hyaluronan Laboratory at Monash University under the direction of Meditech's research director,...
Source: Pharma Business Week (2005-08-15)
|
